Literature DB >> 7127086

Inhibition of dopamine release by melatonin: regional distribution in the rat brain.

N Zisapel, Y Egozi, M Laudon.   

Abstract

Dopamine release evoked by electrical field stimulation of slices from various regions of rat brain was assessed in the presence of 10-10-10-5 M melatonin. Inhibition of dopamine release by melatonin was observed in the ventral hippocampus, medulla pons, preoptic area and median and posterior hypothalamus. No inhibitory effect of melatonin on dopamine release was observed in the cerebral cortex, cerebellum, dorsal hippocampus and striatum. Equal concentrations of melatonin were needed to produce half-maximal inhibition in all the regions affected. The results indicate that the brain sites for inhibitory effect of melatonin on dopamine neurosecretion overlap the sites reportedly involved in its modulation of neuroendocrine functions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127086     DOI: 10.1016/0006-8993(82)90157-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Melatonin receptors revisited.

Authors:  N Zisapel
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 2.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Modulatory effects of melatonin on cadmium-induced changes in biogenic amines in rat hypothalamus.

Authors:  Alejandro Romero; Ana Caride; Natividad Pereiro; Anunciación Lafuente
Journal:  Neurotox Res       Date:  2011-01-11       Impact factor: 3.911

4.  The effects of short photoperiod, pinealectomy, and melatonin treatment on oxytocin synthesis and release in the male syrian hamster.

Authors:  M Juszczak; R W Steger; L Debeljuk; C Fadden; J N Rao; K E Borg; A Bartke
Journal:  Endocrine       Date:  1996-06       Impact factor: 3.633

Review 5.  Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting.

Authors:  N Zisapel
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

6.  Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice.

Authors:  Anthony J Hutchinson; Randall L Hudson; Margarita L Dubocovich
Journal:  J Pineal Res       Date:  2012-06-07       Impact factor: 13.007

7.  Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.

Authors:  Shannon J Clough; Anthony J Hutchinson; Randall L Hudson; Margarita L Dubocovich
Journal:  Physiol Behav       Date:  2014-05-09

8.  Modification by oxazepam of the diurnal variations in brain 125I-melatonin binding sites in sham-operated and pinealectomized rats.

Authors:  Y Anis; I Nir; U Schmidt; N Zisapel
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure.

Authors:  Abla Benleulmi-Chaachoua; Alan Hegron; Marine Le Boulch; Angeliki Karamitri; Marta Wierzbicka; Victoria Wong; Igor Stagljar; Philippe Delagrange; Raise Ahmad; Ralf Jockers
Journal:  Cell Mol Life Sci       Date:  2018-07-24       Impact factor: 9.261

Review 10.  The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

Authors:  Domenico De Berardis; Stefano Marini; Michele Fornaro; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Alessandro Valchera; Giampaolo Perna; Maria-Antonia Quera-Salva; Giovanni Martinotti; Massimo di Giannantonio
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.